nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—bone cancer	0.838	1	CbGaD
Salbutamol—Salmeterol—CYP3A4—bone cancer	0.000346	0.717	CrCbGaD
Salbutamol—Dysuria—Epirubicin—bone cancer	0.000319	0.00197	CcSEcCtD
Salbutamol—Abdominal distension—Doxorubicin—bone cancer	0.000317	0.00196	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Epirubicin—bone cancer	0.000317	0.00196	CcSEcCtD
Salbutamol—Stomatitis—Methotrexate—bone cancer	0.000316	0.00195	CcSEcCtD
Salbutamol—Conjunctivitis—Methotrexate—bone cancer	0.000316	0.00195	CcSEcCtD
Salbutamol—Asthma—Doxorubicin—bone cancer	0.000315	0.00195	CcSEcCtD
Salbutamol—Influenza—Doxorubicin—bone cancer	0.000315	0.00195	CcSEcCtD
Salbutamol—Sweating—Methotrexate—bone cancer	0.000311	0.00192	CcSEcCtD
Salbutamol—Feeling abnormal—Cisplatin—bone cancer	0.000311	0.00192	CcSEcCtD
Salbutamol—Haematuria—Methotrexate—bone cancer	0.00031	0.00191	CcSEcCtD
Salbutamol—Hyperglycaemia—Epirubicin—bone cancer	0.000307	0.0019	CcSEcCtD
Salbutamol—Angina pectoris—Doxorubicin—bone cancer	0.000307	0.0019	CcSEcCtD
Salbutamol—Epistaxis—Methotrexate—bone cancer	0.000306	0.00189	CcSEcCtD
Salbutamol—Drowsiness—Epirubicin—bone cancer	0.000304	0.00188	CcSEcCtD
Salbutamol—Bronchitis—Doxorubicin—bone cancer	0.000303	0.00187	CcSEcCtD
Salbutamol—Body temperature increased—Cisplatin—bone cancer	0.000298	0.00184	CcSEcCtD
Salbutamol—Neuropathy peripheral—Epirubicin—bone cancer	0.000298	0.00184	CcSEcCtD
Salbutamol—Stomatitis—Epirubicin—bone cancer	0.000296	0.00183	CcSEcCtD
Salbutamol—Jaundice—Epirubicin—bone cancer	0.000296	0.00183	CcSEcCtD
Salbutamol—Urinary tract infection—Epirubicin—bone cancer	0.000295	0.00182	CcSEcCtD
Salbutamol—Conjunctivitis—Epirubicin—bone cancer	0.000295	0.00182	CcSEcCtD
Salbutamol—Dysuria—Doxorubicin—bone cancer	0.000295	0.00182	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000293	0.00181	CcSEcCtD
Salbutamol—Haemoglobin—Methotrexate—bone cancer	0.000293	0.00181	CcSEcCtD
Salbutamol—Haemorrhage—Methotrexate—bone cancer	0.000291	0.0018	CcSEcCtD
Salbutamol—Sweating—Epirubicin—bone cancer	0.000291	0.0018	CcSEcCtD
Salbutamol—Haematuria—Epirubicin—bone cancer	0.00029	0.00179	CcSEcCtD
Salbutamol—Pharyngitis—Methotrexate—bone cancer	0.000289	0.00179	CcSEcCtD
Salbutamol—Urinary tract disorder—Methotrexate—bone cancer	0.000288	0.00178	CcSEcCtD
Salbutamol—Epistaxis—Epirubicin—bone cancer	0.000287	0.00177	CcSEcCtD
Salbutamol—Urethral disorder—Methotrexate—bone cancer	0.000286	0.00176	CcSEcCtD
Salbutamol—Sinusitis—Epirubicin—bone cancer	0.000285	0.00176	CcSEcCtD
Salbutamol—Hyperglycaemia—Doxorubicin—bone cancer	0.000284	0.00176	CcSEcCtD
Salbutamol—Drowsiness—Doxorubicin—bone cancer	0.000281	0.00174	CcSEcCtD
Salbutamol—Hypersensitivity—Cisplatin—bone cancer	0.000278	0.00172	CcSEcCtD
Salbutamol—Neuropathy peripheral—Doxorubicin—bone cancer	0.000276	0.0017	CcSEcCtD
Salbutamol—Haemoglobin—Epirubicin—bone cancer	0.000274	0.00169	CcSEcCtD
Salbutamol—Stomatitis—Doxorubicin—bone cancer	0.000274	0.00169	CcSEcCtD
Salbutamol—Jaundice—Doxorubicin—bone cancer	0.000274	0.00169	CcSEcCtD
Salbutamol—Rhinitis—Epirubicin—bone cancer	0.000273	0.00169	CcSEcCtD
Salbutamol—Urinary tract infection—Doxorubicin—bone cancer	0.000273	0.00169	CcSEcCtD
Salbutamol—Conjunctivitis—Doxorubicin—bone cancer	0.000273	0.00169	CcSEcCtD
Salbutamol—Haemorrhage—Epirubicin—bone cancer	0.000273	0.00168	CcSEcCtD
Salbutamol—Tinnitus—Methotrexate—bone cancer	0.000272	0.00168	CcSEcCtD
Salbutamol—Hypoaesthesia—Epirubicin—bone cancer	0.000271	0.00168	CcSEcCtD
Salbutamol—Asthenia—Cisplatin—bone cancer	0.000271	0.00167	CcSEcCtD
Salbutamol—Pharyngitis—Epirubicin—bone cancer	0.000271	0.00167	CcSEcCtD
Salbutamol—Cardiac disorder—Methotrexate—bone cancer	0.00027	0.00167	CcSEcCtD
Salbutamol—Sweating—Doxorubicin—bone cancer	0.000269	0.00166	CcSEcCtD
Salbutamol—Urinary tract disorder—Epirubicin—bone cancer	0.000269	0.00166	CcSEcCtD
Salbutamol—Haematuria—Doxorubicin—bone cancer	0.000268	0.00166	CcSEcCtD
Salbutamol—Connective tissue disorder—Epirubicin—bone cancer	0.000268	0.00166	CcSEcCtD
Salbutamol—Urethral disorder—Epirubicin—bone cancer	0.000267	0.00165	CcSEcCtD
Salbutamol—Epistaxis—Doxorubicin—bone cancer	0.000265	0.00164	CcSEcCtD
Salbutamol—Angiopathy—Methotrexate—bone cancer	0.000264	0.00163	CcSEcCtD
Salbutamol—Sinusitis—Doxorubicin—bone cancer	0.000264	0.00163	CcSEcCtD
Salbutamol—Immune system disorder—Methotrexate—bone cancer	0.000263	0.00163	CcSEcCtD
Salbutamol—Mediastinal disorder—Methotrexate—bone cancer	0.000263	0.00162	CcSEcCtD
Salbutamol—Chills—Methotrexate—bone cancer	0.000261	0.00162	CcSEcCtD
Salbutamol—Diarrhoea—Cisplatin—bone cancer	0.000258	0.00159	CcSEcCtD
Salbutamol—Mental disorder—Methotrexate—bone cancer	0.000255	0.00158	CcSEcCtD
Salbutamol—Tinnitus—Epirubicin—bone cancer	0.000254	0.00157	CcSEcCtD
Salbutamol—Malnutrition—Methotrexate—bone cancer	0.000254	0.00157	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—bone cancer	0.000254	0.00157	CcSEcCtD
Salbutamol—Flushing—Epirubicin—bone cancer	0.000253	0.00156	CcSEcCtD
Salbutamol—Cardiac disorder—Epirubicin—bone cancer	0.000253	0.00156	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—bone cancer	0.000253	0.00156	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—bone cancer	0.000252	0.00156	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—bone cancer	0.000251	0.00155	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—bone cancer	0.00025	0.00155	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—bone cancer	0.000249	0.00154	CcSEcCtD
Salbutamol—Dysgeusia—Methotrexate—bone cancer	0.000248	0.00153	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—bone cancer	0.000248	0.00153	CcSEcCtD
Salbutamol—Angiopathy—Epirubicin—bone cancer	0.000247	0.00153	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—bone cancer	0.000247	0.00153	CcSEcCtD
Salbutamol—Immune system disorder—Epirubicin—bone cancer	0.000246	0.00152	CcSEcCtD
Salbutamol—Mediastinal disorder—Epirubicin—bone cancer	0.000246	0.00152	CcSEcCtD
Salbutamol—Back pain—Methotrexate—bone cancer	0.000245	0.00152	CcSEcCtD
Salbutamol—Chills—Epirubicin—bone cancer	0.000245	0.00151	CcSEcCtD
Salbutamol—Arrhythmia—Epirubicin—bone cancer	0.000244	0.00151	CcSEcCtD
Salbutamol—Vomiting—Cisplatin—bone cancer	0.00024	0.00148	CcSEcCtD
Salbutamol—Mental disorder—Epirubicin—bone cancer	0.000239	0.00148	CcSEcCtD
Salbutamol—Rash—Cisplatin—bone cancer	0.000238	0.00147	CcSEcCtD
Salbutamol—Dermatitis—Cisplatin—bone cancer	0.000238	0.00147	CcSEcCtD
Salbutamol—Malnutrition—Epirubicin—bone cancer	0.000237	0.00147	CcSEcCtD
Salbutamol—Ill-defined disorder—Methotrexate—bone cancer	0.000235	0.00145	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—bone cancer	0.000235	0.00145	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—bone cancer	0.000234	0.00145	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—bone cancer	0.000234	0.00145	CcSEcCtD
Salbutamol—Flatulence—Epirubicin—bone cancer	0.000234	0.00145	CcSEcCtD
Salbutamol—Tension—Epirubicin—bone cancer	0.000233	0.00144	CcSEcCtD
Salbutamol—Dysgeusia—Epirubicin—bone cancer	0.000232	0.00144	CcSEcCtD
Salbutamol—Nervousness—Epirubicin—bone cancer	0.000231	0.00142	CcSEcCtD
Salbutamol—Back pain—Epirubicin—bone cancer	0.00023	0.00142	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—bone cancer	0.000229	0.00141	CcSEcCtD
Salbutamol—Malaise—Methotrexate—bone cancer	0.000229	0.00141	CcSEcCtD
Salbutamol—Muscle spasms—Epirubicin—bone cancer	0.000228	0.00141	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—bone cancer	0.000228	0.00141	CcSEcCtD
Salbutamol—Vertigo—Methotrexate—bone cancer	0.000228	0.00141	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—bone cancer	0.000227	0.0014	CcSEcCtD
Salbutamol—Chills—Doxorubicin—bone cancer	0.000226	0.0014	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—bone cancer	0.000225	0.00139	CcSEcCtD
Salbutamol—Nausea—Cisplatin—bone cancer	0.000224	0.00138	CcSEcCtD
Salbutamol—Cough—Methotrexate—bone cancer	0.000221	0.00137	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—bone cancer	0.000221	0.00137	CcSEcCtD
Salbutamol—Ill-defined disorder—Epirubicin—bone cancer	0.00022	0.00136	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—bone cancer	0.00022	0.00136	CcSEcCtD
Salbutamol—Agitation—Epirubicin—bone cancer	0.000218	0.00135	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—bone cancer	0.000216	0.00134	CcSEcCtD
Salbutamol—Myalgia—Methotrexate—bone cancer	0.000216	0.00133	CcSEcCtD
Salbutamol—Arthralgia—Methotrexate—bone cancer	0.000216	0.00133	CcSEcCtD
Salbutamol—Chest pain—Methotrexate—bone cancer	0.000216	0.00133	CcSEcCtD
Salbutamol—Tension—Doxorubicin—bone cancer	0.000216	0.00133	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—bone cancer	0.000215	0.00133	CcSEcCtD
Salbutamol—Malaise—Epirubicin—bone cancer	0.000214	0.00132	CcSEcCtD
Salbutamol—Discomfort—Methotrexate—bone cancer	0.000213	0.00132	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—bone cancer	0.000213	0.00132	CcSEcCtD
Salbutamol—Vertigo—Epirubicin—bone cancer	0.000213	0.00132	CcSEcCtD
Salbutamol—Syncope—Epirubicin—bone cancer	0.000213	0.00132	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—bone cancer	0.000212	0.00131	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—bone cancer	0.000211	0.0013	CcSEcCtD
Salbutamol—Palpitations—Epirubicin—bone cancer	0.00021	0.0013	CcSEcCtD
Salbutamol—Loss of consciousness—Epirubicin—bone cancer	0.000209	0.00129	CcSEcCtD
Salbutamol—Cough—Epirubicin—bone cancer	0.000207	0.00128	CcSEcCtD
Salbutamol—Anaphylactic shock—Methotrexate—bone cancer	0.000207	0.00128	CcSEcCtD
Salbutamol—Infection—Methotrexate—bone cancer	0.000206	0.00127	CcSEcCtD
Salbutamol—Hypertension—Epirubicin—bone cancer	0.000205	0.00127	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—bone cancer	0.000204	0.00126	CcSEcCtD
Salbutamol—Nervous system disorder—Methotrexate—bone cancer	0.000203	0.00125	CcSEcCtD
Salbutamol—Chest pain—Epirubicin—bone cancer	0.000202	0.00125	CcSEcCtD
Salbutamol—Arthralgia—Epirubicin—bone cancer	0.000202	0.00125	CcSEcCtD
Salbutamol—Myalgia—Epirubicin—bone cancer	0.000202	0.00125	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—bone cancer	0.000202	0.00125	CcSEcCtD
Salbutamol—Anxiety—Epirubicin—bone cancer	0.000201	0.00124	CcSEcCtD
Salbutamol—Skin disorder—Methotrexate—bone cancer	0.000201	0.00124	CcSEcCtD
Salbutamol—Hyperhidrosis—Methotrexate—bone cancer	0.0002	0.00124	CcSEcCtD
Salbutamol—Discomfort—Epirubicin—bone cancer	0.0002	0.00123	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—bone cancer	0.000198	0.00122	CcSEcCtD
Salbutamol—Dry mouth—Epirubicin—bone cancer	0.000198	0.00122	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—bone cancer	0.000197	0.00122	CcSEcCtD
Salbutamol—Anorexia—Methotrexate—bone cancer	0.000197	0.00122	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—bone cancer	0.000197	0.00122	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—bone cancer	0.000194	0.0012	CcSEcCtD
Salbutamol—Oedema—Epirubicin—bone cancer	0.000194	0.0012	CcSEcCtD
Salbutamol—Anaphylactic shock—Epirubicin—bone cancer	0.000194	0.0012	CcSEcCtD
Salbutamol—Hypotension—Methotrexate—bone cancer	0.000193	0.0012	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—bone cancer	0.000193	0.00119	CcSEcCtD
Salbutamol—Infection—Epirubicin—bone cancer	0.000192	0.00119	CcSEcCtD
Salbutamol—Cough—Doxorubicin—bone cancer	0.000192	0.00118	CcSEcCtD
Salbutamol—Shock—Epirubicin—bone cancer	0.000191	0.00118	CcSEcCtD
Salbutamol—Nervous system disorder—Epirubicin—bone cancer	0.00019	0.00117	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—bone cancer	0.00019	0.00117	CcSEcCtD
Salbutamol—Tachycardia—Epirubicin—bone cancer	0.000189	0.00117	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000189	0.00117	CcSEcCtD
Salbutamol—Skin disorder—Epirubicin—bone cancer	0.000188	0.00116	CcSEcCtD
Salbutamol—Hyperhidrosis—Epirubicin—bone cancer	0.000187	0.00116	CcSEcCtD
Salbutamol—Insomnia—Methotrexate—bone cancer	0.000187	0.00116	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—bone cancer	0.000187	0.00116	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—bone cancer	0.000187	0.00116	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—bone cancer	0.000187	0.00116	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—bone cancer	0.000186	0.00115	CcSEcCtD
Salbutamol—Paraesthesia—Methotrexate—bone cancer	0.000186	0.00115	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—bone cancer	0.000185	0.00114	CcSEcCtD
Salbutamol—Anorexia—Epirubicin—bone cancer	0.000185	0.00114	CcSEcCtD
Salbutamol—Dyspnoea—Methotrexate—bone cancer	0.000185	0.00114	CcSEcCtD
Salbutamol—Somnolence—Methotrexate—bone cancer	0.000184	0.00114	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—bone cancer	0.000183	0.00113	CcSEcCtD
Salbutamol—Dyspepsia—Methotrexate—bone cancer	0.000182	0.00113	CcSEcCtD
Salbutamol—Hypotension—Epirubicin—bone cancer	0.000181	0.00112	CcSEcCtD
Salbutamol—Decreased appetite—Methotrexate—bone cancer	0.00018	0.00111	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—bone cancer	0.000179	0.00111	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—bone cancer	0.000179	0.00111	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Methotrexate—bone cancer	0.000179	0.0011	CcSEcCtD
Salbutamol—Fatigue—Methotrexate—bone cancer	0.000179	0.0011	CcSEcCtD
Salbutamol—Infection—Doxorubicin—bone cancer	0.000178	0.0011	CcSEcCtD
Salbutamol—Pain—Methotrexate—bone cancer	0.000177	0.00109	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000177	0.00109	CcSEcCtD
Salbutamol—Shock—Doxorubicin—bone cancer	0.000176	0.00109	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—bone cancer	0.000176	0.00109	CcSEcCtD
Salbutamol—Insomnia—Epirubicin—bone cancer	0.000175	0.00108	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—bone cancer	0.000175	0.00108	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—bone cancer	0.000174	0.00108	CcSEcCtD
Salbutamol—Paraesthesia—Epirubicin—bone cancer	0.000174	0.00107	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—bone cancer	0.000173	0.00107	CcSEcCtD
Salbutamol—Dyspnoea—Epirubicin—bone cancer	0.000173	0.00107	CcSEcCtD
Salbutamol—Somnolence—Epirubicin—bone cancer	0.000172	0.00106	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—bone cancer	0.000171	0.00106	CcSEcCtD
Salbutamol—Feeling abnormal—Methotrexate—bone cancer	0.000171	0.00105	CcSEcCtD
Salbutamol—Dyspepsia—Epirubicin—bone cancer	0.000171	0.00105	CcSEcCtD
Salbutamol—Gastrointestinal pain—Methotrexate—bone cancer	0.000169	0.00105	CcSEcCtD
Salbutamol—Decreased appetite—Epirubicin—bone cancer	0.000168	0.00104	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—bone cancer	0.000168	0.00103	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Epirubicin—bone cancer	0.000167	0.00103	CcSEcCtD
Salbutamol—Fatigue—Epirubicin—bone cancer	0.000167	0.00103	CcSEcCtD
Salbutamol—Pain—Epirubicin—bone cancer	0.000166	0.00102	CcSEcCtD
Salbutamol—Constipation—Epirubicin—bone cancer	0.000166	0.00102	CcSEcCtD
Salbutamol—Urticaria—Methotrexate—bone cancer	0.000164	0.00102	CcSEcCtD
Salbutamol—Abdominal pain—Methotrexate—bone cancer	0.000164	0.00101	CcSEcCtD
Salbutamol—Body temperature increased—Methotrexate—bone cancer	0.000164	0.00101	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000163	0.00101	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—bone cancer	0.000162	0.001	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—bone cancer	0.000161	0.000995	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—bone cancer	0.00016	0.000987	CcSEcCtD
Salbutamol—Feeling abnormal—Epirubicin—bone cancer	0.00016	0.000986	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—bone cancer	0.000159	0.000985	CcSEcCtD
Salbutamol—Gastrointestinal pain—Epirubicin—bone cancer	0.000158	0.000979	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—bone cancer	0.000158	0.000975	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—bone cancer	0.000156	0.000963	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000155	0.000956	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—bone cancer	0.000155	0.000955	CcSEcCtD
Salbutamol—Urticaria—Epirubicin—bone cancer	0.000154	0.000951	CcSEcCtD
Salbutamol—Pain—Doxorubicin—bone cancer	0.000153	0.000947	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—bone cancer	0.000153	0.000947	CcSEcCtD
Salbutamol—Body temperature increased—Epirubicin—bone cancer	0.000153	0.000946	CcSEcCtD
Salbutamol—Abdominal pain—Epirubicin—bone cancer	0.000153	0.000946	CcSEcCtD
Salbutamol—Hypersensitivity—Methotrexate—bone cancer	0.000153	0.000942	CcSEcCtD
Salbutamol—Asthenia—Methotrexate—bone cancer	0.000149	0.000918	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—bone cancer	0.000148	0.000913	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000147	0.000906	CcSEcCtD
Salbutamol—Pruritus—Methotrexate—bone cancer	0.000146	0.000905	CcSEcCtD
Salbutamol—Hypersensitivity—Epirubicin—bone cancer	0.000143	0.000882	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—bone cancer	0.000142	0.00088	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—bone cancer	0.000142	0.000876	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—bone cancer	0.000142	0.000876	CcSEcCtD
Salbutamol—Diarrhoea—Methotrexate—bone cancer	0.000142	0.000875	CcSEcCtD
Salbutamol—Asthenia—Epirubicin—bone cancer	0.000139	0.000859	CcSEcCtD
Salbutamol—Pruritus—Epirubicin—bone cancer	0.000137	0.000847	CcSEcCtD
Salbutamol—Dizziness—Methotrexate—bone cancer	0.000137	0.000846	CcSEcCtD
Salbutamol—Epinephrine—CYP3A4—bone cancer	0.000137	0.283	CrCbGaD
Salbutamol—Diarrhoea—Epirubicin—bone cancer	0.000133	0.000819	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—bone cancer	0.000132	0.000816	CcSEcCtD
Salbutamol—Vomiting—Methotrexate—bone cancer	0.000132	0.000813	CcSEcCtD
Salbutamol—Rash—Methotrexate—bone cancer	0.000131	0.000806	CcSEcCtD
Salbutamol—Dermatitis—Methotrexate—bone cancer	0.00013	0.000806	CcSEcCtD
Salbutamol—Headache—Methotrexate—bone cancer	0.00013	0.000801	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—bone cancer	0.000129	0.000795	CcSEcCtD
Salbutamol—Dizziness—Epirubicin—bone cancer	0.000128	0.000792	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—bone cancer	0.000127	0.000784	CcSEcCtD
Salbutamol—Vomiting—Epirubicin—bone cancer	0.000123	0.000761	CcSEcCtD
Salbutamol—Nausea—Methotrexate—bone cancer	0.000123	0.00076	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—bone cancer	0.000123	0.000758	CcSEcCtD
Salbutamol—Rash—Epirubicin—bone cancer	0.000122	0.000755	CcSEcCtD
Salbutamol—Dermatitis—Epirubicin—bone cancer	0.000122	0.000754	CcSEcCtD
Salbutamol—Headache—Epirubicin—bone cancer	0.000121	0.00075	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—bone cancer	0.000119	0.000732	CcSEcCtD
Salbutamol—Nausea—Epirubicin—bone cancer	0.000115	0.000711	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—bone cancer	0.000114	0.000704	CcSEcCtD
Salbutamol—Rash—Doxorubicin—bone cancer	0.000113	0.000698	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—bone cancer	0.000113	0.000698	CcSEcCtD
Salbutamol—Headache—Doxorubicin—bone cancer	0.000112	0.000694	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—bone cancer	0.000106	0.000658	CcSEcCtD
